OMEPRAZOLE 20MG

OMEPRAZOLE 20MG was reported 1137 times

OMEPRAZOLE 20MG is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PROGRESSIVE CEREBELLAR DEGENERATION 1 0.0909
1 ADMINISTRATION SITE STREAKING 1 0.0909
2 VEILLONELLA INFECTION 1 0.0400
3 SERUM PROCOLLAGEN TYPE I N-TERMINAL PROPEPTIDE INCREASED 1 0.0323
4 NODAL MARGINAL ZONE B-CELL LYMPHOMA 1 0.0294
5 BRANCHIAL CYST 1 0.0286
6 HYPOPARATHYROIDISM SECONDARY 3 0.0259
7 PHENYLKETONURIA 1 0.0222
8 MAGNESIUM METABOLISM DISORDER 1 0.0204
9 TRAUMATIC ARTHRITIS 1 0.0182
10 RENAL HAMARTOMA 1 0.0179
11 CEREBRAL DYSGENESIS 1 0.0167
12 DIURETIC THERAPY 1 0.0139
13 TRACHEAL DEVIATION 1 0.0114
14 CARCINOID TUMOUR OF THE GASTROINTESTINAL TRACT 1 0.0084
15 CONGENITAL CYSTIC LUNG 1 0.0083
16 PRE-EXISTING DISEASE 4 0.0082
17 TETANUS 1 0.0081
18 CARCINOID TUMOUR OF THE STOMACH 1 0.0071
19 PARATHYROID GLAND ENLARGEMENT 1 0.0070
20 DISORDER OF ORBIT 1 0.0069
21 TRACHEAL INJURY 1 0.0068
22 PERIPANCREATIC FLUID COLLECTION 1 0.0066
23 COMBINED IMMUNODEFICIENCY 1 0.0062
24 EYE DEGENERATIVE DISORDER 1 0.0060
25 CUTANEOUS CALCIFICATION 1 0.0055
26 MONOCYTE PERCENTAGE DECREASED 1 0.0054
27 ANASTOMOTIC HAEMORRHAGE 1 0.0053
28 LIP NEOPLASM MALIGNANT STAGE UNSPECIFIED 1 0.0050
29 HYPONATRAEMIC ENCEPHALOPATHY 1 0.0050
30 HUMAN EHRLICHIOSIS 1 0.0048
31 BRACHIAL PLEXOPATHY 1 0.0045
32 SUPERIOR MESENTERIC ARTERY SYNDROME 1 0.0045
33 RECTAL SPASM 1 0.0043
34 VASCULAR PSEUDOANEURYSM RUPTURED 1 0.0043
35 LARYNX IRRITATION 1 0.0043
36 PALATAL SWELLING 1 0.0041
37 METASTASES TO GASTROINTESTINAL TRACT 1 0.0041
38 OESOPHAGEAL SQUAMOUS CELL CARCINOMA 1 0.0041
39 URAEMIC ENCEPHALOPATHY 1 0.0032
40 MENTAL DISORDER DUE TO A GENERAL MEDICAL CONDITION 1 0.0032
41 BLAST CELL CRISIS 1 0.0030
42 ACQUIRED OESOPHAGEAL WEB 1 0.0029
43 DECREASED VIBRATORY SENSE 1 0.0029
44 GASTROENTERITIS CLOSTRIDIAL 1 0.0028
45 INSULIN AUTOIMMUNE SYNDROME 1 0.0028
46 REACTION TO DRUG EXCIPIENTS 6 0.0028
47 ACCELERATED HYPERTENSION 1 0.0026
48 COLON CANCER STAGE III 1 0.0026
49 HYPOPARATHYROIDISM 2 0.0026
50 LARYNGEAL PAIN 1 0.0025
51 DRUG WITHDRAWAL HEADACHE 1 0.0024
52 TONGUE DISCOMFORT 10 0.0024
53 TISSUE INJURY 1 0.0023
54 REFUSAL OF TREATMENT BY RELATIVE 1 0.0022
55 IMPLANT SITE REACTION 1 0.0022
56 BLOOD CHROMOGRANIN A INCREASED 1 0.0022
57 CHOLESTASIS OF PREGNANCY 1 0.0022
58 PRODUCT DOSAGE FORM ISSUE 1 0.0021
59 HYPERGAMMAGLOBULINAEMIA 1 0.0021
60 INJURY CORNEAL 1 0.0019
61 SCROTAL PAIN 1 0.0019
62 HYPERTROPHY 1 0.0018
63 CRYSTALLURIA 1 0.0018
64 EPIGLOTTITIS 1 0.0018
65 AMNIOTIC FLUID VOLUME DECREASED 1 0.0018
66 METAL POISONING 1 0.0017
67 LIMB REDUCTION DEFECT 1 0.0017
68 DYSMETRIA 1 0.0017
69 TETANY 3 0.0016
70 HEPATOBILIARY DISEASE 1 0.0016
71 TRACHEO-OESOPHAGEAL FISTULA 1 0.0016
72 PANCREATIC NEUROENDOCRINE TUMOUR 1 0.0016
73 OESOPHAGEAL ACHALASIA 1 0.0016
74 RESTING TREMOR 1 0.0015
75 SCLERAL DISCOLOURATION 1 0.0015
76 DEVICE BATTERY ISSUE 1 0.0015
77 INJECTION SITE EXFOLIATION 1 0.0015
78 THROAT LESION 1 0.0015
79 CEREBRAL CYST 1 0.0015
80 HYPOMAGNESAEMIA 20 0.0014
81 SYSTEMIC SCLERODERMA 1 0.0014
82 CEREBRAL VASOCONSTRICTION 1 0.0014
83 SPONTANEOUS HAEMATOMA 1 0.0013
84 OBSTRUCTIVE PANCREATITIS 1 0.0013
85 TRANSCRIPTION MEDICATION ERROR 2 0.0013
86 POST-TRAUMATIC NECK SYNDROME 1 0.0012
87 ENDOMETRIAL HYPERPLASIA 1 0.0012
88 CHEMICAL INJURY 1 0.0012
89 HAND-FOOT-AND-MOUTH DISEASE 1 0.0012
90 HYDROTHORAX 1 0.0012
91 OESOPHAGEAL RUPTURE 1 0.0012
92 ORAL DISCOMFORT 16 0.0012
93 THERAPEUTIC PRODUCT CROSS-REACTIVITY 1 0.0011
94 PLEUROTHOTONUS 1 0.0011
95 CEREBRAL TOXOPLASMOSIS 1 0.0011
96 SCROTAL SWELLING 1 0.0011
97 WRONG SCHEDULE 1 0.0010
98 VASCULAR PAIN 1 0.0010
99 INTUSSUSCEPTION 1 0.0010
100 PROSTATE INFECTION 1 0.0010
101 VOCAL CORD DISORDER 2 0.0010
102 INJECTION SITE NECROSIS 2 0.0010
103 GASTRIC PH DECREASED 1 0.0010
104 NON-ALCOHOLIC STEATOHEPATITIS 1 0.0010
105 PHARYNGEAL ERYTHEMA 2 0.0009
106 ASTERIXIS 1 0.0009
107 CEREBRAL ARTERY OCCLUSION 1 0.0009
108 ORCHITIS 1 0.0009
109 RENAL TUBULAR ACIDOSIS 2 0.0009
110 GASTROINTESTINAL TRACT IRRITATION 1 0.0009
111 WRONG DRUG ADMINISTERED 8 0.0009
112 MOANING 1 0.0009
113 SERONEGATIVE ARTHRITIS 1 0.0009
114 CEREBRAL VENTRICLE DILATATION 1 0.0009
115 GRANULOMATOSIS WITH POLYANGIITIS 1 0.0008
116 PENILE SWELLING 1 0.0008
117 TUBULOINTERSTITIAL NEPHRITIS 15 0.0008
118 GLUCOSE URINE PRESENT 1 0.0008
119 LIP HAEMORRHAGE 1 0.0008
120 FAECES HARD 3 0.0008
121 TONIC CLONIC MOVEMENTS 1 0.0008
122 SINUS ARRHYTHMIA 1 0.0008
123 EXPOSURE VIA FATHER 1 0.0008
124 BLOOD LACTIC ACID INCREASED 4 0.0008
125 HYPOVITAMINOSIS 1 0.0008
126 LYMPHOCYTE PERCENTAGE DECREASED 1 0.0007
127 ABDOMINAL RIGIDITY 2 0.0007
128 URETERIC OBSTRUCTION 1 0.0007
129 BEZOAR 1 0.0007
130 BILIARY TRACT DISORDER 1 0.0007
131 PERIPHERAL ARTERY THROMBOSIS 1 0.0007
132 HEART VALVE INCOMPETENCE 2 0.0007
133 HYPOCALCAEMIA 13 0.0007
134 BLOOD PARATHYROID HORMONE DECREASED 1 0.0007
135 NEPHRECTOMY 1 0.0007
136 INTERCEPTED DRUG DISPENSING ERROR 1 0.0007
137 ATRIOVENTRICULAR BLOCK SECOND DEGREE 2 0.0007
138 INTELLECTUAL DISABILITY 1 0.0007
139 VIOLENCE-RELATED SYMPTOM 1 0.0006
140 EYE ALLERGY 1 0.0006
141 YELLOW SKIN 3 0.0006
142 RESPIRATORY RATE DECREASED 2 0.0006
143 INHIBITORY DRUG INTERACTION 1 0.0006
144 PHARYNGEAL PARAESTHESIA 1 0.0006
145 MEDICATION RESIDUE PRESENT 3 0.0006
146 PARAESTHESIA ORAL 9 0.0006
147 DISINHIBITION 1 0.0006
148 ACUTE LEUKAEMIA 1 0.0006
149 LIVER ABSCESS 2 0.0006
150 OROPHARYNGEAL BLISTERING 1 0.0006
151 INTERCEPTED PRODUCT DISPENSING ERROR 1 0.0006
152 TONGUE ULCERATION 2 0.0006
153 LAZINESS 1 0.0006
154 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 6 0.0006
155 REGURGITATION 2 0.0006
156 ACUTE SINUSITIS 1 0.0006
157 SENSITIVITY OF TEETH 1 0.0006
158 KIDNEY FIBROSIS 1 0.0006
159 SPONDYLOLISTHESIS 1 0.0006
160 THYROIDECTOMY 1 0.0006
161 GLOSSITIS 2 0.0006
162 OBSESSIVE THOUGHTS 1 0.0006
163 CHEILITIS 3 0.0006
164 SINUS NODE DYSFUNCTION 1 0.0005
165 HYPERTRICHOSIS 1 0.0005
166 CATHETER PLACEMENT 1 0.0005
167 TUNNEL VISION 1 0.0005
168 ADENOCARCINOMA OF COLON 1 0.0005
169 HEPATIC MASS 1 0.0005
170 ERUCTATION 10 0.0005
171 CONVERSION DISORDER 1 0.0005
172 OESOPHAGEAL PAIN 2 0.0005
173 DRUG SCREEN POSITIVE 4 0.0005
174 CELL DEATH 1 0.0005
175 ALLERGIC REACTION TO EXCIPIENT 1 0.0005
176 LARGE INTESTINAL STENOSIS 1 0.0005
177 CORONARY ARTERY THROMBOSIS 1 0.0005
178 NIPPLE PAIN 1 0.0005
179 DIVERTICULAR PERFORATION 1 0.0005
180 PSYCHOTIC SYMPTOM 1 0.0005
181 SPINA BIFIDA 1 0.0005
182 ATRIAL TACHYCARDIA 1 0.0005
183 MUSCLE FATIGUE 2 0.0005
184 RENAL NEOPLASM 1 0.0005
185 HYPOAESTHESIA ORAL 7 0.0005
186 AMYOTROPHIC LATERAL SCLEROSIS 1 0.0005
187 FAECES DISCOLOURED 10 0.0005
188 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 1 0.0005
189 CLOSTRIDIUM TEST POSITIVE 1 0.0005
190 GASTROINTESTINAL ULCER 1 0.0005
191 FAECES PALE 1 0.0004
192 GASTROINTESTINAL HYPOMOTILITY 1 0.0004
193 GASTRIC POLYPS 1 0.0004
194 DISLOCATION OF VERTEBRA 1 0.0004
195 APHTHOUS STOMATITIS 1 0.0004
196 HAEMANGIOMA 1 0.0004
197 METHAEMOGLOBINAEMIA 1 0.0004
198 PRURITUS GENITAL 1 0.0004
199 PANCREATITIS CHRONIC 1 0.0004
200 COLITIS MICROSCOPIC 2 0.0004
201 PRE-ECLAMPSIA 2 0.0004
202 LONG QT SYNDROME 1 0.0004
203 PAINFUL RESPIRATION 1 0.0004
204 HOSPICE CARE 4 0.0004
205 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 1 0.0004
206 ACUTE PSYCHOSIS 1 0.0004
207 PENIS DISORDER 1 0.0004
208 GASTROINTESTINAL SOUNDS ABNORMAL 2 0.0004
209 PROTEIN URINE PRESENT 2 0.0004
210 DERMATITIS EXFOLIATIVE 2 0.0004
211 INCREASED BRONCHIAL SECRETION 1 0.0004
212 HEPATOSPLENOMEGALY 1 0.0004
213 LIPOMA 1 0.0004
214 POSTMENOPAUSAL HAEMORRHAGE 1 0.0004
215 ANORECTAL DISCOMFORT 2 0.0004
216 HYPERLACTACIDAEMIA 1 0.0004
217 MYCOBACTERIUM AVIUM COMPLEX INFECTION 1 0.0004
218 BREAST SWELLING 1 0.0004
219 FLATULENCE 21 0.0004
220 EAR CONGESTION 1 0.0004
221 SKIN WRINKLING 1 0.0004
222 LUNG CONSOLIDATION 1 0.0004
223 ATYPICAL FEMUR FRACTURE 1 0.0004
224 RETINAL VEIN OCCLUSION 1 0.0003
225 SKIN ATROPHY 2 0.0003
226 NEGATIVE THOUGHTS 1 0.0003
227 LUNG ADENOCARCINOMA 1 0.0003
228 VARICES OESOPHAGEAL 1 0.0003
229 PENILE PAIN 1 0.0003
230 IRON DEFICIENCY ANAEMIA 3 0.0003
231 LARYNGEAL OEDEMA 2 0.0003
232 GASTROOESOPHAGEAL REFLUX DISEASE 26 0.0003
233 NON-CARDIAC CHEST PAIN 1 0.0003
234 FAECAL CALPROTECTIN INCREASED 1 0.0003
235 DRUG EFFECT DECREASED 17 0.0003
236 GLOSSODYNIA 7 0.0003
237 THROAT IRRITATION 14 0.0003
238 VENTRICULAR HYPOKINESIA 1 0.0003
239 CHROMATURIA 7 0.0003
240 CARDIAC FLUTTER 2 0.0003
241 HIATUS HERNIA 4 0.0003
242 OEDEMA MOUTH 1 0.0003
243 COELIAC DISEASE 3 0.0003
244 PRODUCT FORMULATION ISSUE 2 0.0003
245 NEAR DEATH EXPERIENCE 1 0.0003
246 HYPONATRAEMIA 17 0.0003
247 EXPIRED PRODUCT ADMINISTERED 10 0.0003
248 ATRIOVENTRICULAR BLOCK COMPLETE 2 0.0003
249 POTENTIATING DRUG INTERACTION 1 0.0003
250 SUPRAVENTRICULAR EXTRASYSTOLES 1 0.0003
251 AUTOIMMUNE HAEMOLYTIC ANAEMIA 1 0.0003
252 HEPATIC FIBROSIS 1 0.0003
253 INTERNATIONAL NORMALISED RATIO ABNORMAL 1 0.0003
254 CERVICAL VERTEBRAL FRACTURE 1 0.0003
255 EXTRASYSTOLES 2 0.0003
256 LOGORRHOEA 1 0.0003
257 DYSPEPSIA 27 0.0003
258 ASTHMATIC CRISIS 1 0.0003
259 RECTAL DISCHARGE 1 0.0003
260 IMPULSIVE BEHAVIOUR 1 0.0003
261 PHARYNGEAL OEDEMA 4 0.0003
262 EPIGASTRIC DISCOMFORT 1 0.0003
263 DYSGEUSIA 19 0.0003
264 PROSTATOMEGALY 1 0.0003
265 RESPIRATORY ACIDOSIS 1 0.0003
266 EXPOSURE VIA BREAST MILK 1 0.0003
267 CEREBRAL ATROPHY 1 0.0003
268 CREATININE RENAL CLEARANCE DECREASED 1 0.0002
269 FOREIGN BODY 1 0.0002
270 MYASTHENIA GRAVIS 2 0.0002
271 ABNORMAL FAECES 2 0.0002
272 PULSELESS ELECTRICAL ACTIVITY 1 0.0002
273 HYPOKALAEMIA 11 0.0002
274 POOR PERIPHERAL CIRCULATION 1 0.0002
275 INTERVERTEBRAL DISC DISORDER 1 0.0002
276 ABNORMAL SENSATION IN EYE 1 0.0002
277 TENSION HEADACHE 1 0.0002
278 ANURIA 2 0.0002
279 BLOOD MAGNESIUM DECREASED 2 0.0002
280 TONGUE DISCOLOURATION 1 0.0002
281 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 2 0.0002
282 BLOOD CREATINE INCREASED 1 0.0002
283 WHEELCHAIR USER 1 0.0002
284 THIRST 4 0.0002
285 ANAL INCONTINENCE 2 0.0002
286 DRUG EFFECT DELAYED 1 0.0002
287 URINE ABNORMALITY 1 0.0002
288 DISEASE COMPLICATION 1 0.0002
289 LUMBAR VERTEBRAL FRACTURE 1 0.0002
290 NEPHROGENIC ANAEMIA 1 0.0002
291 HEPATIC STEATOSIS 4 0.0002
292 NEPHROPATHY 2 0.0002
293 MIDDLE INSOMNIA 4 0.0002
294 FLANK PAIN 2 0.0002
295 LACERATION 2 0.0002
296 PRODUCTIVE COUGH 10 0.0002
297 HYPOVOLAEMIC SHOCK 1 0.0002
298 LIMB OPERATION 1 0.0002
299 SEROTONIN SYNDROME 4 0.0002
300 VITAMIN D DEFICIENCY 2 0.0002
301 INCORRECT DOSAGE ADMINISTERED 1 0.0002
302 RENAL TUBULAR NECROSIS 2 0.0002
303 HEPATOMEGALY 2 0.0002
304 ABDOMINAL DISCOMFORT 34 0.0002
305 MUCOUS STOOLS 1 0.0002
306 ABDOMINAL TENDERNESS 1 0.0002
307 ABDOMINAL DISTENSION 21 0.0002
308 HYPERNATRAEMIA 1 0.0002
309 HYPERAMMONAEMIA 1 0.0002
310 ABDOMINAL PAIN UPPER 41 0.0002
311 PRODUCT SOLUBILITY ABNORMAL 1 0.0002
312 FEMORAL NECK FRACTURE 1 0.0002
313 INITIAL INSOMNIA 2 0.0002
314 CEREBRAL ISCHAEMIA 1 0.0002
315 MALABSORPTION 1 0.0002
316 NERVOUSNESS 10 0.0002
317 PARTIAL SEIZURES 1 0.0002
318 PRODUCT ODOUR ABNORMAL 2 0.0002
319 POLYARTHRITIS 1 0.0002
320 CLOSTRIDIUM DIFFICILE COLITIS 2 0.0002
321 NYSTAGMUS 1 0.0002
322 RETCHING 4 0.0002
323 FOOD POISONING 1 0.0002
324 HIP SURGERY 1 0.0002
325 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 1 0.0002
326 HYDROCEPHALUS 1 0.0002
327 JAW DISORDER 1 0.0002
328 ASTHENOPIA 1 0.0002
329 CHOKING SENSATION 1 0.0002
330 INJECTION SITE INJURY 1 0.0002
331 LIP SWELLING 6 0.0002
332 UPPER GASTROINTESTINAL HAEMORRHAGE 3 0.0002
333 STATUS EPILEPTICUS 2 0.0002
334 THERAPY CESSATION 9 0.0002
335 PRODUCT SUBSTITUTION ISSUE 10 0.0002
336 SOCIAL AVOIDANT BEHAVIOUR 1 0.0002
337 HYPERVENTILATION 1 0.0002
338 SKIN WARM 1 0.0002
339 URINE ODOUR ABNORMAL 1 0.0002
340 PLEURISY 1 0.0002
341 MYOCLONUS 2 0.0002
342 SYMPTOM RECURRENCE 1 0.0002
343 MENTAL IMPAIRMENT 4 0.0002
344 NOCTURIA 2 0.0002
345 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 1 0.0002
346 DERMATITIS ACNEIFORM 1 0.0002
347 OLIGURIA 1 0.0002
348 HEPATIC CIRRHOSIS 3 0.0002
349 NASAL DRYNESS 1 0.0002
350 BLEPHAROSPASM 1 0.0002
351 SCREAMING 1 0.0002
352 INCOHERENT 1 0.0002
353 TENDON DISORDER 1 0.0002
354 REFUSAL OF TREATMENT BY PATIENT 1 0.0002
355 MUSCLE SPASMS 28 0.0002
356 GASTRITIS 4 0.0002
357 ORAL CANDIDIASIS 2 0.0002
358 DIARRHOEA 98 0.0002
359 HAEMATOCRIT DECREASED 3 0.0002
360 CORONAVIRUS INFECTION 1 0.0002
361 APPETITE DISORDER 1 0.0002
362 EYE HAEMORRHAGE 2 0.0001
363 LEFT VENTRICULAR DYSFUNCTION 1 0.0001
364 QUALITY OF LIFE DECREASED 2 0.0001
365 PRODUCT PHYSICAL ISSUE 3 0.0001
366 METASTASES TO LYMPH NODES 1 0.0001
367 POSTOPERATIVE WOUND INFECTION 1 0.0001
368 WRONG PRODUCT ADMINISTERED 1 0.0001
369 THROAT TIGHTNESS 4 0.0001
370 PRODUCT TASTE ABNORMAL 2 0.0001
371 ABNORMAL LOSS OF WEIGHT 1 0.0001
372 GINGIVAL BLEEDING 2 0.0001
373 POLLAKIURIA 6 0.0001
374 AUTOIMMUNE HEPATITIS 1 0.0001
375 HYPERTRANSAMINASAEMIA 1 0.0001
376 CONSTIPATION 31 0.0001
377 EATING DISORDER 3 0.0001
378 RETINAL HAEMORRHAGE 1 0.0001
379 PRODUCT SUPPLY ISSUE 1 0.0001
380 IRRITABLE BOWEL SYNDROME 3 0.0001
381 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 1 0.0001
382 PRURITUS GENERALISED 3 0.0001
383 PANIC REACTION 1 0.0001
384 TONGUE DISORDER 1 0.0001
385 CLOSTRIDIUM DIFFICILE INFECTION 3 0.0001
386 INTERVERTEBRAL DISC PROTRUSION 3 0.0001
387 PANIC ATTACK 5 0.0001
388 ACCIDENTAL OVERDOSE 5 0.0001
389 MELAENA 3 0.0001
390 BLINDNESS TRANSIENT 1 0.0001
391 SENSITIVE SKIN 1 0.0001
392 HYPOPHOSPHATAEMIA 1 0.0001
393 SNEEZING 3 0.0001
394 KETOACIDOSIS 1 0.0001
395 PAROSMIA 1 0.0001
396 ECONOMIC PROBLEM 2 0.0001
397 TOXIC EPIDERMAL NECROLYSIS 2 0.0001
398 HAEMODYNAMIC INSTABILITY 1 0.0001
399 HYPERTHERMIA 1 0.0001
400 ACIDOSIS 1 0.0001
401 BOWEL MOVEMENT IRREGULARITY 1 0.0001
402 DISSOCIATION 1 0.0001
403 SHOCK 3 0.0001
404 MUSCLE TWITCHING 3 0.0001
405 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 1 0.0001
406 PELVIC FRACTURE 1 0.0001
407 TORSADE DE POINTES 1 0.0001
408 CYANOSIS 2 0.0001
409 FURUNCLE 1 0.0001
410 RENAL CYST 1 0.0001
411 METABOLIC ACIDOSIS 4 0.0001
412 RHINITIS 1 0.0001
413 MUSCLE DISORDER 1 0.0001
414 NEURALGIA 3 0.0001
415 DRY MOUTH 10 0.0001
416 MUSCULAR WEAKNESS 14 0.0001
417 BLOOD POTASSIUM INCREASED 2 0.0001
418 HICCUPS 1 0.0001
419 HYPERAESTHESIA 1 0.0001
420 VENTRICULAR TACHYCARDIA 2 0.0001
421 ABDOMINAL PAIN LOWER 3 0.0001
422 HYPOPHAGIA 3 0.0001
423 FACIAL PARALYSIS 1 0.0001
424 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 3 0.0001
425 MYOPATHY 1 0.0001
426 SKIN SWELLING 1 0.0001
427 ORTHOSTATIC HYPOTENSION 2 0.0001
428 NAIL DISORDER 1 0.0001
429 BURNING SENSATION 8 0.0001
430 GROIN PAIN 1 0.0001
431 SPINAL OSTEOARTHRITIS 1 0.0001
432 DRUG INEFFECTIVE 150 0.0001
433 COLD SWEAT 2 0.0001
434 DRUG INTERACTION 18 0.0001
435 LUNG INFILTRATION 1 0.0001
436 HEAD DISCOMFORT 2 0.0001
437 RESPIRATORY RATE INCREASED 1 0.0001
438 FACIAL PAIN 1 0.0001
439 GASTROINTESTINAL INFECTION 1 0.0001
440 JAUNDICE 3 0.0001
441 FREQUENT BOWEL MOVEMENTS 3 0.0001
442 PALPITATIONS 13 0.0001
443 LUPUS-LIKE SYNDROME 1 0.0001
444 DRUG EFFECT INCOMPLETE 4 0.0001
445 LOWER RESPIRATORY TRACT INFECTION 5 0.0001
446 DISEASE PROGRESSION 13 0.0001
447 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 6 0.0001
448 INCREASED TENDENCY TO BRUISE 1 0.0001
449 BLOOD THYROID STIMULATING HORMONE INCREASED 1 0.0001
450 UROSEPSIS 1 0.0001
451 DIVERTICULITIS 3 0.0001
452 INTERVERTEBRAL DISC DEGENERATION 1 0.0001
453 HYPERSENSITIVITY 20 0.0001
454 DEMENTIA 3 0.0001
455 THINKING ABNORMAL 2 0.0001
456 BLISTER 6 0.0001
457 INCORRECT DRUG ADMINISTRATION DURATION 3 0.0001
458 SPINAL DISORDER 1 0.0001
459 SPUTUM DISCOLOURED 1 0.0001
460 BLOOD URINE PRESENT 2 0.0001
461 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 1 0.0001
462 BLOOD PRESSURE INCREASED 16 0.0001
463 ACUTE KIDNEY INJURY 16 0.0001
464 ACUTE RESPIRATORY FAILURE 2 0.0001
465 ATELECTASIS 1 0.0001
466 HERNIA 2 0.0001
467 ORAL HERPES 2 0.0001
468 INFLAMMATORY BOWEL DISEASE 1 0.0001
469 ASCITES 3 0.0001
470 KIDNEY INFECTION 2 0.0001
471 THERAPY CHANGE 1 0.0001
472 URINARY INCONTINENCE 3 0.0001
473 BRAIN INJURY 1 0.0001
474 EMPHYSEMA 1 0.0001
475 INTENTIONAL SELF-INJURY 2 0.0001
476 CONFUSIONAL STATE 16 0.0001
477 DRY THROAT 1 0.0001
478 MOTOR DYSFUNCTION 1 0.0001
479 THERAPY INTERRUPTED 7 0.0001
480 FEELING HOT 6 0.0001
481 NEUTROPHIL COUNT INCREASED 1 0.0001
482 DEHYDRATION 13 0.0001
483 RIB FRACTURE 2 0.0001
484 LIMB DISCOMFORT 3 0.0001
485 TREATMENT FAILURE 8 0.0001
486 RHABDOMYOLYSIS 4 0.0001
487 URTICARIA 16 0.0001
488 CONDITION AGGRAVATED 29 0.0001
489 HEAD INJURY 3 0.0001
490 RENAL PAIN 1 0.0001
491 HYPOTHYROIDISM 3 0.0001
492 DECREASED ACTIVITY 1 0.0001
493 ALTERED STATE OF CONSCIOUSNESS 2 0.0001
494 BIPOLAR DISORDER 1 0.0001
495 PRODUCT DISPENSING ERROR 2 0.0001
496 PERIPHERAL SWELLING 14 0.0001
497 INJECTION SITE NODULE 1 0.0001
498 SKIN DISORDER 3 0.0001
499 NERVE INJURY 1 0.0001
500 THERAPEUTIC RESPONSE UNEXPECTED 4 0.0001
501 BLOOD CALCIUM DECREASED 1 0.0001
502 TRANSIENT ISCHAEMIC ATTACK 3 0.0001
503 DERMATITIS CONTACT 1 0.0001
504 INTERNAL HAEMORRHAGE 1 0.0001
505 MYOCARDITIS 1 0.0001
506 DELIRIUM 3 0.0001
507 CHEST PAIN 16 0.0001
508 CAESAREAN SECTION 1 0.0001
509 PRURITUS 33 0.0001
510 VASCULITIS 1 0.0001
511 HYPERKALAEMIA 3 0.0001
512 SPLENOMEGALY 1 0.0001
513 SPINAL PAIN 1 0.0001
514 MIGRAINE 8 0.0001
515 MUSCLE RIGIDITY 1 0.0001
516 POLYNEUROPATHY 1 0.0001
517 ELECTROCARDIOGRAM QT PROLONGED 3 0.0001
518 FIBROMYALGIA 2 0.0001
519 RESTLESSNESS 3 0.0001
520 CYTOPENIA 1 0.0001
521 RESPIRATORY DEPRESSION 1 0.0001
522 ENCEPHALOPATHY 2 0.0001
523 MUSCLE SPASTICITY 1 0.0001
524 GLOMERULAR FILTRATION RATE DECREASED 1 0.0001
525 BALANCE DISORDER 7 0.0001
526 GENERALISED OEDEMA 1 0.0001
527 HEPATIC FUNCTION ABNORMAL 3 0.0001
528 TOOTH EXTRACTION 1 0.0001
529 HYPOAESTHESIA 12 0.0001
530 SECRETION DISCHARGE 1 0.0001
531 DERMATITIS ALLERGIC 1 0.0001
532 BRAIN OEDEMA 1 0.0001
533 HAEMATEMESIS 2 0.0001
534 HEPATITIS 2 0.0001
535 CHEST DISCOMFORT 8 0.0001
536 ERECTILE DYSFUNCTION 2 0.0001
537 HYPERHIDROSIS 10 0.0001
538 RASH GENERALISED 2 0.0001
539 INJECTION SITE INDURATION 1 0.0001
540 PLATELET COUNT INCREASED 1 0.0001
541 BLOOD CREATININE INCREASED 5 0.0001
542 SEDATION 2 0.0001
543 PARAESTHESIA 12 0.0001
544 DIZZINESS 38 0.0001
545 BEDRIDDEN 1 0.0001
546 TOOTH INFECTION 1 0.0001
547 PULMONARY CONGESTION 1 0.0001
548 OROPHARYNGEAL PAIN 7 0.0001
549 ADVERSE REACTION 1 0.0001
550 EAR INFECTION 2 0.0001
551 FEAR 2 0.0001
552 DISTURBANCE IN ATTENTION 4 0.0001
553 BLOOD BILIRUBIN INCREASED 2 0.0001
554 TACHYPNOEA 1 0.0001
555 IMPAIRED GASTRIC EMPTYING 1 0.0001
556 ACUTE HEPATIC FAILURE 1 0.0001
557 OSTEOPOROSIS 3 0.0001
558 ANAPHYLACTIC REACTION 4 0.0001
559 MENTAL STATUS CHANGES 2 0.0001
560 APHONIA 1 0.0001
561 NECK PAIN 4 0.0001
562 RENAL IMPAIRMENT 6 0.0001
563 BLOOD TEST ABNORMAL 1 0.0001
564 SKIN REACTION 1 0.0001
565 SLEEP DISORDER 5 0.0001
566 NAUSEA 56 0.0001
567 ANXIETY 20 0.0001
568 INTERNATIONAL NORMALISED RATIO INCREASED 2 0.0001
569 RED BLOOD CELL COUNT DECREASED 2 0.0001
570 CARDIOGENIC SHOCK 1 0.0001
571 ANOSMIA 1 0.0001
572 DYSPNOEA 39 0.0001
573 DYSSTASIA 2 0.0001
574 ACUTE MYOCARDIAL INFARCTION 2 0.0001
575 ANGIOEDEMA 3 0.0001
576 SKIN HAEMORRHAGE 1 0.0001
577 PULMONARY OEDEMA 3 0.0001
578 GASTROINTESTINAL DISORDER 6 0.0001
579 HAEMORRHAGE INTRACRANIAL 1 0.0001
580 RASH 29 0.0001
581 BLOOD POTASSIUM DECREASED 2 0.0001
582 HEPATIC FAILURE 2 0.0001
583 PRODUCT QUALITY ISSUE 9 0.0001
584 LACRIMATION INCREASED 2 0.0001
585 STOMATITIS 4 0.0001
586 DISCOMFORT 4 0.0001
587 SUICIDAL IDEATION 6 0.0001
588 DRUG DISPENSING ERROR 1 0.0001
589 EPILEPSY 2 0.0001
590 NEPHROLITHIASIS 3 0.0001
591 HIP ARTHROPLASTY 1 0.0001
592 SKIN DISCOLOURATION 3 0.0001
593 MYALGIA 11 0.0001
594 MUSCULOSKELETAL CHEST PAIN 1 0.0001
595 BACK PAIN 15 0.0001
596 SOMNOLENCE 13 0.0001
597 LUNG INFECTION 1 0.0001
598 EJECTION FRACTION DECREASED 1 0.0001
599 NERVOUS SYSTEM DISORDER 2 0.0001
600 MENINGIOMA 1 0.0001
601 SWOLLEN TONGUE 2 0.0001
602 PRODUCT USE COMPLAINT 1 0.0001
603 SICKLE CELL ANAEMIA WITH CRISIS 1 0.0001
604 BLOOD LACTATE DEHYDROGENASE INCREASED 1 0.0001
605 DISEASE RECURRENCE 3 0.0001
606 PNEUMOTHORAX 1 0.0001
607 RESPIRATORY TRACT CONGESTION 1 0.0001
608 PREMATURE DELIVERY 1 0.0001
609 OBESITY 1 0.0001
610 MOOD SWINGS 2 0.0001
611 FEELING ABNORMAL 15 0.0001
612 HIP FRACTURE 2 0.0001
613 CHOLELITHIASIS 2 0.0001
614 MANIA 1 0.0001
615 STAPHYLOCOCCAL INFECTION 2 0.0001
616 SEIZURE 7 0.0001
617 HEART RATE INCREASED 6 0.0001
618 GENERALISED TONIC-CLONIC SEIZURE 1 0.0001
619 DRUG LEVEL INCREASED 1 0.0001
620 DECREASED APPETITE 14 0.0001
621 LEUKOPENIA 3 0.0001
622 SYNCOPE 6 0.0001
623 BLOOD UREA INCREASED 1 0.0001
624 SKIN EXFOLIATION 5 0.0001
625 HAEMOGLOBIN DECREASED 6 0.0001
626 MUSCULOSKELETAL DISCOMFORT 1 0.0001
627 PARANOIA 1 0.0001
628 NIGHTMARE 2 0.0001
629 DEVICE DEFECTIVE 1 0.0001
630 LOCAL SWELLING 1 0.0001
631 MUSCULOSKELETAL PAIN 3 0.0001
632 RASH MACULAR 2 0.0001
633 EOSINOPHILIA 1 0.0001
634 HYPOXIA 2 0.0001
635 PANCREATITIS 3 0.0001
636 BRADYCARDIA 3 0.0001
637 INSOMNIA 15 0.0001
638 PLATELET COUNT DECREASED 6 0.0001
639 TACHYCARDIA 5 0.0001
640 ISCHAEMIC STROKE 1 0.0001
641 ABDOMINAL PAIN 13 0.0001
642 CEREBRAL HAEMORRHAGE 2 0.0001
643 ASTHENIA 21 0.0001
644 ARTHRALGIA 23 0.0001
645 TOOTHACHE 1 0.0001
646 CRYING 2 0.0001
647 RESTLESS LEGS SYNDROME 1 0.0001
648 MALAISE 24 0.0001
649 AGITATION 4 0.0001
650 HAEMATOCHEZIA 3 0.0001
651 FATIGUE 42 0.0001
652 EYE SWELLING 2 0.0001
653 BACTERIAL INFECTION 1 0.0001
654 EPISTAXIS 4 0.0001
655 VOMITING 25 0.0001
656 DYSPNOEA EXERTIONAL 2 0.0001
657 INTESTINAL OBSTRUCTION 2 0.0001
658 BLOOD SODIUM DECREASED 1 0.0001
659 COLITIS 2 0.0001
660 RENAL FAILURE 7 0.0001
661 FEELING JITTERY 1 0.0001
662 CHOLESTASIS 1 0.0001
663 DYSTONIA 1 0.0001
664 EAR PAIN 1 0.0001
665 CHILLS 6 0.0001
666 SKIN FISSURES 1 0.0001
667 DISABILITY 1 0.0001
668 SINUS DISORDER 1 0.0001
669 ABNORMAL BEHAVIOUR 2 0.0001
670 DISORIENTATION 2 0.0001
671 PREGNANCY 1 0.0000
672 SPINAL FRACTURE 1 0.0000
673 HYPOTENSION 10 0.0000
674 PLEURAL EFFUSION 3 0.0000
675 VERTIGO 3 0.0000
676 DYSKINESIA 2 0.0000
677 BODY TEMPERATURE INCREASED 1 0.0000
678 PULMONARY HYPERTENSION 1 0.0000
679 KNEE ARTHROPLASTY 1 0.0000
680 MOUTH ULCERATION 1 0.0000
681 LOSS OF CONSCIOUSNESS 6 0.0000
682 IMPAIRED WORK ABILITY 1 0.0000
683 POOR QUALITY SLEEP 1 0.0000
684 RHINORRHOEA 3 0.0000
685 INCORRECT PRODUCT ADMINISTRATION DURATION 1 0.0000
686 AMNESIA 3 0.0000
687 MENTAL DISORDER 2 0.0000
688 PRODUCT DOSE OMISSION 3 0.0000
689 GAMMA-GLUTAMYLTRANSFERASE INCREASED 1 0.0000
690 MATERNAL EXPOSURE DURING PREGNANCY 4 0.0000
691 ORAL PAIN 1 0.0000
692 THERAPY NON-RESPONDER 2 0.0000
693 PANCREATITIS ACUTE 1 0.0000
694 HEART RATE IRREGULAR 1 0.0000
695 PAIN IN EXTREMITY 13 0.0000
696 HEPATIC ENZYME INCREASED 3 0.0000
697 DEPRESSION 10 0.0000
698 TINNITUS 2 0.0000
699 HEADACHE 27 0.0000
700 TREMOR 7 0.0000
701 FALL 14 0.0000
702 COMA 2 0.0000
703 ANAEMIA 8 0.0000
704 SKIN BURNING SENSATION 3 0.0000
705 RASH ERYTHEMATOUS 2 0.0000
706 BLOOD GLUCOSE DECREASED 2 0.0000
707 HEPATIC CANCER 1 0.0000
708 JOINT SWELLING 5 0.0000
709 LOCALISED INFECTION 1 0.0000
710 HYPOGLYCAEMIA 2 0.0000
711 ATRIAL FIBRILLATION 4 0.0000
712 URINARY TRACT INFECTION 7 0.0000
713 CEREBRAL INFARCTION 1 0.0000
714 LUNG DISORDER 2 0.0000
715 LIVER INJURY 1 0.0000
716 ALOPECIA 8 0.0000
717 ABASIA 1 0.0000
718 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
719 AGEUSIA 1 0.0000
720 DRY EYE 2 0.0000
721 AGGRESSION 2 0.0000
722 FLUID RETENTION 2 0.0000
723 COUGH 11 0.0000
724 ERYTHEMA 8 0.0000
725 ACCIDENTAL EXPOSURE TO PRODUCT 4 0.0000
726 ANAPHYLACTIC SHOCK 1 0.0000
727 UNRESPONSIVE TO STIMULI 1 0.0000
728 HAEMATOMA 1 0.0000
729 DIPLOPIA 1 0.0000
730 RESPIRATORY TRACT INFECTION 1 0.0000
731 DEAFNESS 1 0.0000
732 MUCOSAL INFLAMMATION 1 0.0000
733 SPEECH DISORDER 2 0.0000
734 ARTHRITIS 3 0.0000
735 JOINT STIFFNESS 1 0.0000
736 DEPRESSED MOOD 2 0.0000
737 HYPERTENSION 8 0.0000
738 PYREXIA 13 0.0000
739 BLOOD GLUCOSE INCREASED 7 0.0000
740 DEATH 32 0.0000
741 OVERDOSE 8 0.0000
742 RASH PRURITIC 2 0.0000
743 OEDEMA 2 0.0000
744 GAIT DISTURBANCE 7 0.0000
745 VISION BLURRED 5 0.0000
746 ABNORMAL DREAMS 1 0.0000
747 GASTROINTESTINAL HAEMORRHAGE 3 0.0000
748 HAEMOPTYSIS 1 0.0000
749 OXYGEN SATURATION DECREASED 2 0.0000
750 TARDIVE DYSKINESIA 1 0.0000
751 PAIN IN JAW 1 0.0000
752 ANGINA PECTORIS 1 0.0000
753 HYPERSOMNIA 1 0.0000
754 DRUG WITHDRAWAL SYNDROME 3 0.0000
755 PAIN 21 0.0000
756 BONE PAIN 2 0.0000
757 NASAL CONGESTION 2 0.0000
758 PNEUMONIA 11 0.0000
759 RENAL INJURY 1 0.0000
760 ADVERSE DRUG REACTION 3 0.0000
761 IRRITABILITY 2 0.0000
762 APHASIA 1 0.0000
763 SUICIDE ATTEMPT 2 0.0000
764 DRUG ADMINISTRATION ERROR 1 0.0000
765 ALANINE AMINOTRANSFERASE INCREASED 2 0.0000
766 HOSPITALISATION 5 0.0000
767 GYNAECOMASTIA 1 0.0000
768 FEMUR FRACTURE 1 0.0000
769 VISUAL IMPAIRMENT 4 0.0000
770 WEIGHT DECREASED 9 0.0000
771 BONE DENSITY DECREASED 1 0.0000
772 DRUG-INDUCED LIVER INJURY 1 0.0000
773 CYSTITIS 1 0.0000
774 INTENTIONAL OVERDOSE 2 0.0000
775 CONTUSION 3 0.0000
776 NIGHT SWEATS 1 0.0000
777 EYE DISORDER 1 0.0000
778 BLOOD PRESSURE DECREASED 2 0.0000
779 VIRAL INFECTION 1 0.0000
780 FUNGAL INFECTION 1 0.0000
781 URINARY RETENTION 1 0.0000
782 ANGER 1 0.0000
783 FLUSHING 3 0.0000
784 GASTRIC DISORDER 1 0.0000
785 C-REACTIVE PROTEIN INCREASED 1 0.0000
786 HYPERGLYCAEMIA 1 0.0000
787 RESPIRATORY FAILURE 2 0.0000
788 DYSURIA 1 0.0000
789 THROMBOCYTOPENIA 3 0.0000
790 WEIGHT INCREASED 6 0.0000
791 DYSARTHRIA 1 0.0000
792 INCORRECT DOSE ADMINISTERED 6 0.0000
793 CARDIAC FAILURE 2 0.0000
794 THROMBOSIS 2 0.0000
795 BLINDNESS 1 0.0000
796 LUNG NEOPLASM MALIGNANT 1 0.0000
797 CARDIAC ARREST 2 0.0000
798 COMPLETED SUICIDE 2 0.0000
799 CARDIO-RESPIRATORY ARREST 1 0.0000
800 WITHDRAWAL SYNDROME 1 0.0000
801 TOXICITY TO VARIOUS AGENTS 4 0.0000
802 OSTEOARTHRITIS 1 0.0000
803 RENAL FAILURE ACUTE 1 0.0000
804 VAGINAL HAEMORRHAGE 1 0.0000
805 DEVICE DISLOCATION 1 0.0000
806 SEPTIC SHOCK 1 0.0000
807 MUSCULOSKELETAL STIFFNESS 2 0.0000
808 LIVER DISORDER 1 0.0000
809 DRY SKIN 3 0.0000
810 COLITIS ULCERATIVE 1 0.0000
811 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
812 MEMORY IMPAIRMENT 3 0.0000
813 SKIN IRRITATION 1 0.0000
814 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
815 RENAL DISORDER 1 0.0000
816 BLOOD CHOLESTEROL INCREASED 1 0.0000
817 SWELLING 2 0.0000
818 ARRHYTHMIA 1 0.0000
819 DYSPHAGIA 2 0.0000
820 PULMONARY EMBOLISM 2 0.0000
821 NEUROPATHY PERIPHERAL 2 0.0000
822 MULTIPLE SCLEROSIS 1 0.0000
823 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
824 CELLULITIS 1 0.0000
825 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 4 0.0000
826 INFLAMMATION 1 0.0000
827 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
828 ECZEMA 1 0.0000
829 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
830 TREATMENT NONCOMPLIANCE 1 0.0000
831 DRUG DOSE OMISSION 3 0.0000
832 MEDICATION ERROR 1 0.0000
833 SEPSIS 2 0.0000
834 PANCYTOPENIA 1 0.0000
835 EYE PAIN 1 0.0000
836 CONVULSION 1 0.0000
837 HERPES ZOSTER 1 0.0000
838 LETHARGY 1 0.0000
839 EYE IRRITATION 1 0.0000
840 GENERAL PHYSICAL HEALTH DETERIORATION 2 0.0000
841 MYOCARDIAL INFARCTION 3 0.0000
842 DYSPHONIA 1 0.0000
843 SURGERY 1 0.0000
844 WHEEZING 1 0.0000
845 THERAPEUTIC RESPONSE DECREASED 1 0.0000
846 ILL-DEFINED DISORDER 1 0.0000
847 PRODUCT USE ISSUE 3 0.0000
848 DEEP VEIN THROMBOSIS 1 0.0000
849 SWELLING FACE 1 0.0000
850 INFUSION RELATED REACTION 1 0.0000
851 NEOPLASM MALIGNANT 1 0.0000
852 NEUTROPENIA 2 0.0000
853 INJECTION SITE REACTION 1 0.0000
854 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1 0.0000
855 INFECTION 2 0.0000
856 HALLUCINATION 1 0.0000
857 HOT FLUSH 1 0.0000
858 UNEVALUABLE EVENT 1 0.0000
859 ACNE 1 0.0000
860 CHRONIC KIDNEY DISEASE 1 0.0000
861 DIABETES MELLITUS 1 0.0000
862 CARDIAC FAILURE CONGESTIVE 1 0.0000
863 PROSTATE CANCER 1 0.0000
864 FOETAL EXPOSURE DURING PREGNANCY 1 0.0000
865 INFLUENZA LIKE ILLNESS 1 0.0000
866 DRUG ABUSE 1 0.0000
867 ADVERSE EVENT 1 0.0000
868 BREAST CANCER 1 0.0000
869 CARDIAC DISORDER 1 0.0000
870 DRUG INTOLERANCE 1 0.0000
871 SINUSITIS 1 0.0000
872 HAEMORRHAGE 1 0.0000
873 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
874 RHEUMATOID ARTHRITIS 1 0.0000
875 OEDEMA PERIPHERAL 1 0.0000
876 INJECTION SITE ERYTHEMA 1 0.0000
877 INJECTION SITE PAIN 2 0.0000
878 DRUG DEPENDENCE 1 0.0000
879 CEREBROVASCULAR ACCIDENT 1 0.0000
880 NASOPHARYNGITIS 1 0.0000
881 PRODUCT USE IN UNAPPROVED INDICATION 1 0.0000
882 OFF LABEL USE 2 0.0000